	Inter-Vendor Variability of Perfusion Parameters Derived from Dynamic Contrast-Enhanced MRI in Patients with Prostate Cancer. Tomography Kim M, Kim SH, Kim JY. PMID: 42506856 [PubMed - indexed for MEDLINE]
	Vaccine Therapy for the Management of Penile Cancer: Evidence, Opportunities and Challenges. Vaccines (Basel) Hatoum F, Nehme R, Fazili A, Miller J, Johnson JS, Le C, Spiess PE, Chahoud J. PMID: 42506634 [PubMed]
	PSMA PET/CT-Guided Multimodal Therapy for Pelvic Lymph Node Positive and De Novo Low-Volume Metastatic Prostate Cancer: A Gulf Region Single-Institution Experience. Diseases Pervez N, Khan BM, Usmani S, Al-Sayegh H, Al Amri I, Alfishawy M, Yilmaz S, Al Saadi S, Al Harthy M, Ahmed J, Almandhari Z. PMID: 42505560 [PubMed]
	Renal Involvement in Indolent and Aggressive B-Cell Neoplasms: A Comparative Study of Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma and Diffuse Large B-Cell Lymphoma. Curr Oncol Zhao Y, Wang B, Liu H, Yang X, Lai Z, Tang B, Xie W, Ling H, Xie S, Guo S, Yu X, Dong Y. PMID: 42505222 [PubMed - indexed for MEDLINE]
	Evaluation of Diagnostic Performance and Inter-Reader Agreement of Prostate Imaging After Focal Ablation (PI-FAB) on Post-Focal Therapy (FT) Magnetic Resonance Imaging (MRI). Curr Oncol Hang G, Lee ZR, Lai AL, Velaga J, Ho HT, Lam SXL, Tan YG, Ngo NT, Yuen JSP, Khor LY, Chua MLK, Tay KJ, Law YM. PMID: 42505219 [PubMed - indexed for MEDLINE]
	NGS-Based Genomic Profiling Identifies Independent Predictors of Time to Castration Resistance in Hormone-Sensitive Prostate Cancer: A Retrospective Real-World Study. Curr Oncol Turan M, Balta MÇ. PMID: 42505218 [PubMed - indexed for MEDLINE]
	Transition from Oncologist- to Therapist-Led MRI-Guided Ultra-Hypofractionated Adaptive Prostate Radiation Therapy: Evaluation of Early Clinical Outcomes. Curr Oncol Moreira A, Rosewall T, Dang J, Kim A, Santiago AT, Mesci A, Gutierrez E, Bayley A, McPartlin A, Glicksman RM, Berlin A, Winter J, Li W, Chung P. PMID: 42505200 [PubMed - indexed for MEDLINE]
	Kidney Injury Molecule-1 (KIM-1) in Renal Cell Carcinoma: Biological Foundations and Emerging Clinical Applications. Curr Oncol Talao JK, Correa R, Gunaratnam L, Fernandes R. PMID: 42505180 [PubMed - indexed for MEDLINE]
	Management of high-risk non-muscle invasive bladder cancer: a real-world study in North America, Europe and Japan. Future Oncol Bedke J, Eccleston A, Unsworth M, Brinkmann J, Chang J, Koshy A, Manuel L, Skilling J, Biondi E, Brown E, Ford C, Steinberg G, Lotan Y, Loriot Y, Rodriguez Faba O. PMID: 42504607 [PubMed - as supplied by publisher]
	Molecular Construction and Anti-Bladder Cancer Study of Novel TOP1/PARP1 Dual-Target Inhibitors. J Med Chem Wang W, Li D, Liu J, Li L, Zhang Q, Zhang F, Liu Y, Zhang Y, Meng S, Shi X, Wang H, Li Q, Zhang D, Mao Z. PMID: 42504569 [PubMed - as supplied by publisher]
	Active surveillance for intermediate-risk prostate cancer: a systematic review and pooled analysis. BJU Int Uleri A, Cella L, Long-Depaquit T, Sordelli F, Farré A, Caballero V, Comet J, Rajwa P, Diamand R, Tombal B, Roupret M, Kasivisvanathan V, Leapman MS, Ploussard G, Baboudjian M. PMID: 42503039 [PubMed - as supplied by publisher]
	Exploratory Time-Dependent Patterns in Estimated Treatment Effect of Talazoparib Plus Enzalutamide in HRR Non-Deficient or Unknown Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the TALAPRO-2 Trial. Int J Urol Yajima S, Yoshida S, Chen W, Fukushima H, Tanaka H, Sato H, Hirakawa A, Masuda H, Fujii Y. PMID: 42502892 [PubMed - indexed for MEDLINE]
	Identifying and characterizing the germinal genetic landscape of men with prostate cancer: A real-life, retrospective, multicenter study. Genet Med Open Svirsky R, Sonnenfeld B, Kedar I, Linial M, Azulay N, Sharabi-Nov A, Shalev H, Goldberg Y. PMID: 42502690 [PubMed]
	Evaluating Locally Deployed Large Language Models for Ga-68 PSMA PET/CT Report Mining in Prostate Cancer. Nucl Med Mol Imaging Chaudhary J, Sharma PD, Kumar S, Takalkar N, Kumar R, Haresh KP, Das CJ, Sahoo RK, Kaushal S, Kalaivani M, Khairwa H, Pandey AK. PMID: 42502653 [PubMed]
	Beyond EMT: Mesenchymal drift as an emerging driver of stromal-immune reprogramming in prostate cancer. iScience Zhang Z, Liu F, Liu S, Ning H, Sun Y, Wu F. PMID: 42502394 [PubMed]
	Preoperative prediction of positive surgical margins in prostate cancer using multimodal deep learning model: a multicenter study. Abdom Radiol (NY) Fu X, Bao J, Qiao X, Shen J, Zhang Y, Jin P, Ji Y, Zhang J, Su Y, Ji L, Li Z, Hu C, Lu J, Wang X, Shen H, Liu J. PMID: 42501097 [PubMed - as supplied by publisher]
	Impact of tumor immunotherapy on kidney injury and multi-organ outcomes: a mechanistic and clinical perspective. Front Immunol Jiang L, Wang J, Xiong S, Min S, Gong N. PMID: 42500665 [PubMed - indexed for MEDLINE]
	First-Line Treatment Strategies in IMDC Favourable-Risk Metastatic Clear Cell Renal Cell Carcinoma. Oncol Res Valdés A, González-Montero J, Rojas C, Burotto M. PMID: 42500582 [PubMed - indexed for MEDLINE]
	Immunohistochemical Expression of Novel Therapeutic Targets in Squamous Cell Carcinoma of the Bladder. Oncol Res Frey LJ, Lache N, Fischer ND, Rölz N, Frey L, Haack M, Duwe G, Porubsky S, Haferkamp A, Wagner DC, Brandt MP. PMID: 42500580 [PubMed - indexed for MEDLINE]
	Integrative genomic profiling identifies MLPH as a candidate gene in prostate cancer. Front Med (Lausanne) Wang R, Wang J, Zhao Z, Hu X. PMID: 42500538 [PubMed]

Articles 1 - 20 / 180313

Page 1 of 9016



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy